Trial
NCT04139915
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Phase IIIWITHDRAWNEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Restorbio Inc.
Collaborators
—
Condition
Clinically Symptomatic Respiratory Illness
Intervention
Dactolisib
Why stopped
Phase 3 trial RTB-101-204 study did not meet its primary endpoint
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-22